Company page
Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd. is a public company traded under the ticker GLMD in the American market. With a market capitalization of approximately $4.46 million, the company focuses on developing innovative therapies for liver diseases. Galmed aims to address unmet medical needs through its research and development efforts.
- Ticker
- GLMD:NASDAQ
- Asset type
- Stock
- Market cap
- $4.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD